GLP-1 receptor agonist injections, such as Mounjaro and Wegovy, are supported by robust clinical evidence, demonstrating 15-25% weight loss in trials
Omzo's weight-loss page states that "many members see up to 25% body weight reduction over time" - with the key qualifiers being "many" (not all), "up to 25%" (a ceiling, not an average), and "over time" (no specific timeframe defined)
The most common side effects are gastrointestinal, including nausea, vomiting, diarrhoea, and abdominal discomfort, affecting up to 40% of patients initially
Virtual Convenience: Our program is fully virtual, meaning you can access your free consultation and receive ongoing care from the comfort of your home
How to mix Retatrutide with BAC water
C., Knauf, F., Demuth, H